Replies to post #123669 on Biotech Values

[oc631]

What's the story on this one patient? Did they discontinue treatment due to a safety issue? Is there anything to be concerned about here?

I'm second guessing whether interferon was administered on the first day. If anyone knows please post. I'll send a message to VRUS IR tomorrow to confirm details.

Not a safety issue.